HIGHLIGHTS
- who: NAFLD-associated HCC and collaborators from the Tongji University, China have published the research work: Fine-tuning of regulatory T cells is indispensable for the metabolic steatosis-related hepatocellular carcinoma: A review, in the Journal: (JOURNAL)
- what: Chronic hepatic diseases, such as ALD and NAFLD, are emerging as the foremost cause of liver cancer and morbidity worldwide.
- future: Investigations are necessary to improve the understanding of mechanisms underlying ALD and provide aid in finding novel therapeutic targets to treat AH and ALD. absolute Treg population in AH regardless of chronic hepatopathy symptoms . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.